219 related articles for article (PubMed ID: 21788392)
1. A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development.
Geiss BJ; Stahla-Beek HJ; Hannah AM; Gari HH; Henderson BR; Saeedi BJ; Keenan SM
J Biomol Screen; 2011 Sep; 16(8):852-61. PubMed ID: 21788392
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme.
Stahla-Beek HJ; April DG; Saeedi BJ; Hannah AM; Keenan SM; Geiss BJ
J Virol; 2012 Aug; 86(16):8730-9. PubMed ID: 22674988
[TBL] [Abstract][Full Text] [Related]
3. Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus.
Bollati M; Milani M; Mastrangelo E; Ricagno S; Tedeschi G; Nonnis S; Decroly E; Selisko B; de Lamballerie X; Coutard B; Canard B; Bolognesi M
J Mol Biol; 2009 Jan; 385(1):140-52. PubMed ID: 18976670
[TBL] [Abstract][Full Text] [Related]
4. Analysis of flavivirus NS5 methyltransferase cap binding.
Geiss BJ; Thompson AA; Andrews AJ; Sons RL; Gari HH; Keenan SM; Peersen OB
J Mol Biol; 2009 Feb; 385(5):1643-54. PubMed ID: 19101564
[TBL] [Abstract][Full Text] [Related]
5. Aptamer Displacement Screen for Flaviviral RNA Methyltransferase Inhibitors.
Falk SP; Weisblum B
J Biomol Screen; 2014 Sep; 19(8):1147-53. PubMed ID: 24793430
[TBL] [Abstract][Full Text] [Related]
6. Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme.
Henderson BR; Saeedi BJ; Campagnola G; Geiss BJ
PLoS One; 2011; 6(10):e25795. PubMed ID: 22022449
[TBL] [Abstract][Full Text] [Related]
7. Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase.
Brecher M; Chen H; Liu B; Banavali NK; Jones SA; Zhang J; Li Z; Kramer LD; Li H
PLoS One; 2015; 10(6):e0130062. PubMed ID: 26098995
[TBL] [Abstract][Full Text] [Related]
8. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme.
Feibelman KM; Fuller BP; Li L; LaBarbera DV; Geiss BJ
Antiviral Res; 2018 Jun; 154():124-131. PubMed ID: 29680670
[TBL] [Abstract][Full Text] [Related]
9. Structure and functionality in flavivirus NS-proteins: perspectives for drug design.
Bollati M; Alvarez K; Assenberg R; Baronti C; Canard B; Cook S; Coutard B; Decroly E; de Lamballerie X; Gould EA; Grard G; Grimes JM; Hilgenfeld R; Jansson AM; Malet H; Mancini EJ; Mastrangelo E; Mattevi A; Milani M; Moureau G; Neyts J; Owens RJ; Ren J; Selisko B; Speroni S; Steuber H; Stuart DI; Unge T; Bolognesi M
Antiviral Res; 2010 Aug; 87(2):125-48. PubMed ID: 19945487
[TBL] [Abstract][Full Text] [Related]
10. Structure of the methyltransferase domain from the Modoc virus, a flavivirus with no known vector.
Jansson AM; Jakobsson E; Johansson P; Lantez V; Coutard B; de Lamballerie X; Unge T; Jones TA
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):796-803. PubMed ID: 19622863
[TBL] [Abstract][Full Text] [Related]
11. Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323.
Bullard KM; Gullberg RC; Soltani E; Steel JJ; Geiss BJ; Keenan SM
PLoS One; 2015; 10(6):e0130083. PubMed ID: 26075394
[TBL] [Abstract][Full Text] [Related]
12. Crystal Structures of Flavivirus NS5 Guanylyltransferase Reveal a GMP-Arginine Adduct.
Jia H; Zhong Y; Peng C; Gong P
J Virol; 2022 Jul; 96(14):e0041822. PubMed ID: 35758665
[TBL] [Abstract][Full Text] [Related]
13. A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme.
Bullard-Feibelman KM; Fuller BP; Geiss BJ
PLoS One; 2016; 11(7):e0158923. PubMed ID: 27427769
[TBL] [Abstract][Full Text] [Related]
14. The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure.
Issur M; Geiss BJ; Bougie I; Picard-Jean F; Despins S; Mayette J; Hobdey SE; Bisaillon M
RNA; 2009 Dec; 15(12):2340-50. PubMed ID: 19850911
[TBL] [Abstract][Full Text] [Related]
15. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus.
Lim SV; Rahman MB; Tejo BA
BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S24. PubMed ID: 22373153
[TBL] [Abstract][Full Text] [Related]
16. Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition.
Milani M; Mastrangelo E; Bollati M; Selisko B; Decroly E; Bouvet M; Canard B; Bolognesi M
Antiviral Res; 2009 Jul; 83(1):28-34. PubMed ID: 19501254
[TBL] [Abstract][Full Text] [Related]
17. Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.
Pearson LA; Green CJ; Lin D; Petit AP; Gray DW; Cowling VH; Fordyce EAF
SLAS Discov; 2021 Jul; 26(6):749-756. PubMed ID: 33724070
[TBL] [Abstract][Full Text] [Related]
18. Strategies Towards Protease Inhibitors for Emerging Flaviviruses.
Nitsche C
Adv Exp Med Biol; 2018; 1062():175-186. PubMed ID: 29845533
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
[TBL] [Abstract][Full Text] [Related]
20. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
